Taking The Supply Chain Pain Out Of Healthcare Mergers And Acquisitions

Add bookmark

According to a study by the Harvard Business Review, 70-90% of mergers and acquisitions fail.

It’s a disconcertingly high rate – particularly when you consider that the cause cited for most failures wasn’t technological, financial or product-related. It was due to the process of the integration itself.

For companies in the healthcare sector, that process can be particularly fraught – given the nature of the products, the complexity of the supply chains and the stringent regulations involved. Fortunately, there are practical, tactical strategies that can decisively impact the final outcome.

In our experience, a major restructuring is an opportunity to create transformational change that significantly enhances long-term competitiveness and performance. In this white paper, we outline some very pragmatic, actionable strategies we’ve gleaned in our experience working in this sector.

[inlinead]

Benefits of Reading this Whitepaper:

  1. Advice on how the best manage the integration process.
  2. Insight into how successfully harmonising and optimizing supply chains can avoid a lot of long-term pain, and smooth out a disruptive process.
  3. Turning risk into opportunity: We discuss several practical processes and protocols that can greatly influence the outcome of a major transition.

 

Challenges This Whitepaper Will Address:

  1. Preventing the integrity of the supply chain from becoming an inevitable fall-out from large scale restructuring.
  2. Pains from duplication as a result of a merger or acquisition

 

Click to download your complimentary whitepaper below.

Upcoming Events

Pharma Contract Manufacturing

23 - 25 March 2026

Mercure Hotel MOA Berlin, Germany

Pharma Contract Manufacturing

SmartLab Exchange USA

April 20-21, 2026

The Logan, Philadelphia, USA

SmartLab Exchange USA

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended